缺血性心力衰竭中正电子发射断层显像定量指标的预后价值
本研究纳入254例接受负荷与静息心肌灌注显像及存活心肌检测的缺血性心力衰竭患者,中位随访3.3年期间170例(67%)发生主要不良心脏事件。多变量Cox模型显示仅心肌血流储备(MFR)显著预测MACE(p=0.013),MFR每增加1的校正风险比为0.63(95%CI 0.45–0.91),将MFR纳入风险评估模型可增量改善MACE预测(似然比卡方检验16=48.61 vs 15=39.20;p=0.002)。作者结论认为定量PET心肌血流指标均改善风险分层,但MFR作为预后指标似乎略优于其他指标。
要点
- 在缺血性心力衰竭患者中,MFR是唯一在多变量模型中显著预测MACE的定量PET指标(p=0.013)。
- MFR每增加1,MACE校正风险比为0.63(95%CI 0.45–0.91),提示MFR越高风险越低。
- 将MFR加入风险评估模型可增量改善MACE预测(p=0.002)。
核心结论
- 在缺血性心力衰竭患者中,定量PET心肌血流指标均改善风险分层。
- 在假设生成性分析中,MFR作为预后指标似乎略优于其他定量PET指标。
研究设计与样本
- 研究为单中心队列的回顾性分析,纳入254例转诊行负荷与静息心肌灌注显像及存活心肌PET检测的患者。
- 主要不良心脏事件(MACE)包括死亡、复苏成功的心脏性猝死、心脏移植、急性冠脉综合征、心力衰竭住院和晚期血运重建。
- 中位随访3.3年,170例(67%)发生MACE。
诊断标准与关键数值
- 多变量Cox比例风险模型纳入多个定量PET指标时,仅MFR显著预测MACE(p=0.013)。
- 校正年龄、症状严重程度、糖尿病、既往心肌梗死或血运重建、三支病变、肾功能不全、射血分数以及缺血、瘢痕和冬眠心肌的存在与负荷后,MFR与MACE强相关(MFR每增加1的校正风险比0.63;95%CI 0.45–0.91)。
- 将MFR纳入风险评估模型可增量改善MACE预测(似然比卡方检验16=48.61 vs 卡方检验15=39.20;p=0.002)。
临床应用与阅片要点
- 作者结论认为定量PET心肌血流指标均改善缺血性心力衰竭患者的风险分层。
- 作者在假设生成性分析中认为MFR作为预后指标似乎略优于其他定量PET指标。
局限性
- 原文写明本研究为单中心队列的回顾性分析。
- 原文将MFR优于其他指标的分析表述为假设生成性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to investigate the prognostic and clinical value of quantitative positron emission tomographic (PET) metrics in patients with ischemic heart failure.
BACKGROUND: Although myocardial flow reserve (MFR) is a strong predictor of cardiac risk in patients without heart failure, it is unknown whether quantitative PET metrics improve risk stratification in patients with ischemic heart failure.
METHODS: The study included 254 patients referred for stress and rest myocardial perfusion imaging and viability testing using PET. Major adverse cardiac event(s) (MACE) consisted of death, resuscitated sudden cardiac death, heart transplantation, acute coronary syndrome, hospitalization for heart failure, and late revascularization.
RESULTS: MACE occurred in 170 patients (67%) during a median follow-up of 3.3 years. In a multivariate Cox proportional hazards model including multiple quantitative PET metrics, only MFR predicted MACE significantly (p = 0.013). Beyond age, symptom severity, diabetes mellitus, previous myocardial infarction or revascularization, 3-vessel disease, renal insufficiency, ejection fraction, as well as presence and burden of ischemia, scar, and hibernating myocardium, MFR was strongly associated with MACE (adjusted hazard ratio per increase in MFR by 1: 0.63; 95% confidence interval: 0.45 to 0.91). Incorporation of MFR into a risk assessment model incrementally improved the prediction of MACE (likelihood ratio chi-square test [16] = 48.61 vs. chi-square test [15] = 39.20; p = 0.002).
CONCLUSIONS: In this retrospective analysis of a single-center cohort, quantitative PET metrics of myocardial blood flow all improved risk stratification in patients with ischemic heart failure. However, in a hypothesis-generating analysis, MFR appears modestly superior to the other metrics as a prognostic index.
引用
- Benz DC, Kaufmann PA, von Felten E, et al. Prognostic Value of Quantitative Metrics From Positron Emission Tomography in Ischemic Heart Failure. JACC Cardiovasc Imaging. 2020. PMID: 32771569. doi:10.1016/j.jcmg.2020.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。